ATA421482A - Verfahren zur herstellung neuer optisch aktiver oder racemischer prostaglandinderivate - Google Patents

Verfahren zur herstellung neuer optisch aktiver oder racemischer prostaglandinderivate

Info

Publication number
ATA421482A
ATA421482A AT0421482A AT421482A ATA421482A AT A421482 A ATA421482 A AT A421482A AT 0421482 A AT0421482 A AT 0421482A AT 421482 A AT421482 A AT 421482A AT A421482 A ATA421482 A AT A421482A
Authority
AT
Austria
Prior art keywords
prostagland
racemic
derivatives
optically active
producing new
Prior art date
Application number
AT0421482A
Other languages
English (en)
Other versions
AT392964B (de
Inventor
Franco Faustini
Vittoria Villa
Carmelo Gandolfi
Salle Enrico Di
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of ATA421482A publication Critical patent/ATA421482A/de
Application granted granted Critical
Publication of AT392964B publication Critical patent/AT392964B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT4214/82A 1981-11-27 1982-11-18 Verfahren zur herstellung neuer optisch aktiver oder racemischer prostaglandinderivate AT392964B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8135799 1981-11-27

Publications (2)

Publication Number Publication Date
ATA421482A true ATA421482A (de) 1990-12-15
AT392964B AT392964B (de) 1991-07-25

Family

ID=10526190

Family Applications (1)

Application Number Title Priority Date Filing Date
AT4214/82A AT392964B (de) 1981-11-27 1982-11-18 Verfahren zur herstellung neuer optisch aktiver oder racemischer prostaglandinderivate

Country Status (19)

Country Link
US (1) US4543353A (de)
JP (1) JPS58103356A (de)
AT (1) AT392964B (de)
AU (1) AU552847B2 (de)
BE (1) BE895137A (de)
CA (1) CA1237718A (de)
CH (1) CH656877A5 (de)
DE (1) DE3241399A1 (de)
DK (1) DK528982A (de)
FI (1) FI77442C (de)
FR (1) FR2517302A1 (de)
GB (1) GB2111986B (de)
IE (1) IE54347B1 (de)
IL (1) IL67103A (de)
IT (1) IT1153080B (de)
NL (1) NL8204611A (de)
SE (1) SE454588B (de)
SU (2) SU1301309A3 (de)
ZA (1) ZA827825B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2130575B (en) * 1982-11-09 1985-12-11 Erba Farmitalia Amide derivatives of 13, 14-didehydro-cycloalkyl-prostaglandins
GB8329559D0 (en) * 1983-11-04 1983-12-07 Erba Farmitalia Furyl derivatives of 16-substituted prostaglandins preparations
US4877871A (en) * 1988-06-14 1989-10-31 Nabisco Brands, Inc. Synthesis of sucrose polyester
US5972991A (en) * 1992-09-21 1999-10-26 Allergan Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
JP4834224B2 (ja) 1999-03-05 2011-12-14 デューク ユニバーシティ Ｃ１６不飽和ｆｐ−選択的プロスタグランジン類縁体
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US7351404B2 (en) 2002-02-04 2008-04-01 Allergan, Inc. Method of enhancing hair growth
US8758733B2 (en) 2002-02-04 2014-06-24 Allergan, Inc. Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
US9216183B2 (en) 2002-02-04 2015-12-22 Allergan, Inc. Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
US7851504B2 (en) * 2005-03-16 2010-12-14 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
WO2010102078A1 (en) 2009-03-04 2010-09-10 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US20090221703A1 (en) * 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
US20090238763A1 (en) 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
AU2006349143B2 (en) * 2006-10-02 2013-07-18 Techfields Biochem Co. Ltd Positively charged water-soluble prodrugs of prostaglandins and related compounds with very high skin penetration rates
US7507817B2 (en) * 2006-11-17 2009-03-24 Allergan, Inc. Prostaglandin prodrugs
KR20150058566A (ko) * 2007-06-04 2015-05-28 테크필즈 인크 매우 높은 피부 및 막 침투율을 가지는 ｎｓａｉａ 약물전구체 및 이들의 새로운 의약적 용도
US7964595B2 (en) * 2008-01-18 2011-06-21 Allergan, Inc. Thiophenyl prostaglandin derivatives for treating glaucoma and ocular hypertension
JP2011520811A (ja) * 2008-05-09 2011-07-21 アラーガン インコーポレイテッド 治療用の置換チアゾリジノン類、オキサゾリジノン類および関連化合物
CA2723894A1 (en) * 2008-05-09 2009-11-12 Allergan, Inc. Therapeutic substituted hydantoins, and related compounds
US8623918B2 (en) 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8722739B2 (en) * 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US20100204335A1 (en) * 2008-12-01 2010-08-12 Allergan, Inc. Kit and composition for eyelash growth
KR20210123406A (ko) 2008-12-04 2021-10-13 충시 위 고투과력을 가진 조성물 및 이의 적용
US9149484B2 (en) 2009-11-09 2015-10-06 Allergan, Inc. Compositions and methods for stimulating hair growth
MX361709B (es) 2009-11-09 2018-12-07 Allergan Inc Composiciones y metodos para estimular el crecimiento del cabello.
US9522153B2 (en) 2009-12-22 2016-12-20 Allergan, Inc. Compositions and methods for lowering intraocular pressure
US8859616B2 (en) 2011-01-21 2014-10-14 Allergan, Inc. Compounds and methods for enhancing hair growth
JP5925158B2 (ja) * 2013-06-04 2016-05-25 テックフィールズ バイオケム カンパニー リミテッド 非常に高い皮膚浸透率を有するプロスタグランジン及び関連化合物の正荷電水溶性プロドラッグ
JP6030168B2 (ja) * 2015-03-09 2016-11-24 テックフィールズ バイオケム カンパニー リミテッド 非常に高い皮膚浸透率を有するプロスタグランジン及び関連化合物の正荷電水溶性プロドラッグ
JP6306067B2 (ja) * 2016-01-08 2018-04-04 テックフィールズ バイオケム カンパニー リミテッド 非常に高い皮膚浸透率を有するプロスタグランジン及び関連化合物の正荷電水溶性プロドラッグ

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE445717C (de) * 1924-05-16 1927-06-17 Chr Jonathan Sternkopf Vorrichtung zum Herstellen von Holzschliff fuer die Papier- u. dgl. Fabrikation
GB1425961A (en) * 1972-04-13 1976-02-25 Erba Carlo Spa Prostanoic acid derivatives
IT1053781B (it) * 1974-09-25 1981-10-10 Erba C S P A Ora Farmitalia Omega nor cicloalcil 13.14 deidro prostaglandine
IL51877A (en) * 1976-06-01 1981-09-13 Carlo Erba Sa -nor-16-benzyl or phenoxy-13,14-dehydro-prostaglandins and process for their preparation
FI71138C (fi) * 1976-12-31 1986-11-24 Erba Farmitalia Foerfarande foer framstaellning av terapeutiskt aktiva bisykliska prostaglandiner
IT1088966B (it) * 1977-11-15 1985-06-10 Erba Carlo Spa 13,14-dideidro-prostaglandine
SE446993B (sv) * 1980-07-09 1986-10-20 Mo Och Domsjoe Ab Forfarande for framstellning av blekt slipmassa
SE434069B (sv) * 1980-07-09 1984-07-02 Mo Och Domsjoe Ab Forfarande for framstellning av slipmassa

Also Published As

Publication number Publication date
IE822568L (en) 1983-05-27
CH656877A5 (de) 1986-07-31
IL67103A (en) 1986-11-30
BE895137A (fr) 1983-05-25
FI824017L (fi) 1983-05-28
SE8206731L (sv) 1983-05-28
SE8206731D0 (sv) 1982-11-25
IE54347B1 (en) 1989-08-30
IT8224327A1 (it) 1984-05-19
ZA827825B (en) 1983-08-31
IT1153080B (it) 1987-01-14
FI824017A0 (fi) 1982-11-23
AT392964B (de) 1991-07-25
AU8979782A (en) 1983-06-02
NL8204611A (nl) 1983-06-16
FR2517302B1 (de) 1984-12-14
FI77442B (fi) 1988-11-30
DE3241399A1 (de) 1983-06-01
DK528982A (da) 1983-05-28
SU1301309A3 (ru) 1987-03-30
IT8224327A0 (it) 1982-11-19
US4543353A (en) 1985-09-24
CA1237718A (en) 1988-06-07
DE3241399C2 (de) 1990-10-31
GB2111986A (en) 1983-07-13
JPH0369899B2 (de) 1991-11-05
AU552847B2 (en) 1986-06-26
FR2517302A1 (fr) 1983-06-03
GB2111986B (en) 1985-05-15
IL67103A0 (en) 1983-02-23
SU1321372A3 (ru) 1987-06-30
FI77442C (fi) 1989-03-10
JPS58103356A (ja) 1983-06-20
SE454588B (sv) 1988-05-16

Similar Documents

Publication Publication Date Title
ATA421482A (de) Verfahren zur herstellung neuer optisch aktiver oder racemischer prostaglandinderivate
AT373599B (de) Verfahren zur herstellung neuer rifamycinderivate
AT389302B (de) Verfahren zur herstellung neuer 3-benzylidencamphersulfonamidderivate
ATA376184A (de) Verfahren zur herstellung neuer polysubstituierter naphthalinderivate
AT377982B (de) Verfahren zur herstellung eines neuen racemischen oder optisch aktiven pyrrolidin-derivats
ATA337185A (de) Verfahren zur herstellung neuer flavolignanderivate
AT379399B (de) Verfahren zur herstellung von optisch aktiven penemen
ATA233086A (de) Verfahren zur herstellung neuer peptidantibiotika
ATA260781A (de) Verfahren zur herstellung neuer indenderivate un ihrer salze
ATA124285A (de) Verfahren zur herstellung neuer iminothiazolidinderivate
ATA444982A (de) Verfahren zur herstellung neuer bisindolalkaloidderivate
ATA335685A (de) Verfahren zur herstellung neuer thienopyridinderivate
AT384804B (de) Verfahren zur herstellung neuer carbazinsaeurederivate
ATA110680A (de) Verfahren zur herstellung neuer o-trimethyl- silyl-cellulosen
ATA371584A (de) Verfahren zur herstellung neuer cephalosporanderivate
AT376217B (de) Verfahren zur herstellung neuer 3-chlorchinolinderivate
ATA222981A (de) Verfahren zur herstellung neuer alkoxyalkanoylcarnitinhydrohalogeniden
AT387015B (de) Verfahren zur herstellung neuer acylaminophenolderivate
AT386210B (de) Verfahren zur herstellung neuer 4-carbamoyloxyoxa-zaphosphorine
AT376657B (de) Verfahren zur herstellung neuer thiocarnitine
AT381097B (de) Verfahren zur herstellung neuer thiazolintriazinderivate
AT362346B (de) Verfahren zur herstellung von optisch aktiven oder racemischen 1-oxo-2-alkenyl-3-methyl- cyclopent-2-en-4-yl-cyclopropancarboxylaten
AT382866B (de) Verfahren zur herstellung von benzylalkoholderivaten und ihren salzen
ATA229985A (de) Verfahren zur herstellung neuer carbonsaeure-amido-thiolcarbamat-derivate
AT380885B (de) Verfahren zur herstellung neuer organophosphonothioderivate

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee